Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference
09 January 2023 - 7:13AM
Absci Corporation (Nasdaq: ABSI), a generative AI drug creation
company, today announced the company will be participating in the
upcoming 41st Annual J.P. Morgan Healthcare Conference in San
Francisco, CA.
Absci management is scheduled to present on Tuesday, January
10th at 5:15 p.m. Pacific Time (8:15 p.m. Eastern Time). This
presentation time has been updated from a previous announcement and
reflects the current schedule. Interested parties may access a live
and archived webcast of the presentation on the company’s investor
relations website at: investors.absci.com.
About Absci
Absci is the drug and target discovery company harnessing deep
learning AI and synthetic biology to expand the therapeutic
potential of proteins. We built our Integrated Drug Creation™
platform to identify novel drug targets, discover optimal
biotherapeutic candidates, and generate the cell lines to
manufacture them in a single efficient process. Biotech and pharma
innovators partner with us to create the next generation of
protein-based drugs, including Bionic™ proteins containing
nonstandard amino acids, and other novel drug designs that may be
impossible to make with other technologies. Our goal is to enable
the development of better medicines by Translating Ideas into
Drugs™. For more information visit www.absci.com and follow us on
social media: Twitter: @Abscibio, LinkedIn: @absci, and subscribe
to our Absci YouTube channel.
Availability of Other Information about
Absci
Investors and others should note that we routinely communicate
with investors and the public using our website (www.absci.com) and
our investor relations website (investors.absci.com), including
without limitation, through the posting of investor presentations,
SEC filings, press releases, public conference calls and webcasts
on these websites, as well as on Twitter, LinkedIn and YouTube. The
information that we post on these websites and social media outlets
could be deemed to be material information. As a result, investors,
the media, and others interested in Absci are encouraged to review
this information on a regular basis. The contents of our website
and social media postings, or any other website that may be
accessed from our website or social media postings, shall not be
deemed incorporated by reference in any filing under the Securities
Act of 1933, as amended.
Investor Contactinvestors@absci.com
Media Contactpress@absci.com
AbSci (NASDAQ:ABSI)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbSci (NASDAQ:ABSI)
Historical Stock Chart
From Apr 2023 to Apr 2024